Prostaciklinski receptor (ili prostaglandinski I2 receptor, IP1) je receptor za prostaciklin.
On je član familije G-protein spregnutih receptora. Prostaciklin, glavni proizvod ciklooksigenaze u makrovaskularnom endotelu, uzrokuje potentnu vazodilataciju i inhibiciju agregacije trombocita putem vezivanja za ovaj receptor.[1]
Coleman RA, Smith WL, Narumiya S (1994). „International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.”. Pharmacol. Rev.46 (2): 205–29. PMID7938166.
Rauvala H, Peng HB (1997). „HB-GAM (heparin-binding growth-associated molecule) and heparin-type glycans in the development and plasticity of neuron-target contacts.”. Prog. Neurobiol.52 (2): 127–44. DOI:10.1016/S0301-0082(97)00007-5. PMID9185236.
Boie Y, Rushmore TH, Darmon-Goodwin A, et al. (1994). „Cloning and expression of a cDNA for the human prostanoid IP receptor.”. J. Biol. Chem.269 (16): 12173–8. PMID7512962.
Ogawa Y, Tanaka I, Inoue M, et al. (1995). „Structural organization and chromosomal assignment of the human prostacyclin receptor gene.”. Genomics27 (1): 142–8. DOI:10.1006/geno.1995.1016. PMID7665161.
Duncan AM, Anderson LL, Funk CD, et al. (1995). „Chromosomal localization of the human prostanoid receptor gene family.”. Genomics25 (3): 740–2. DOI:10.1016/0888-7543(95)80022-E. PMID7759114.
Nakagawa O, Tanaka I, Usui T, et al. (1994). „Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system.”. Circulation90 (4): 1643–7. PMID7923647.
Bonaldo MF, Lennon G, Soares MB (1997). „Normalization and subtraction: two approaches to facilitate gene discovery.”. Genome Res.6 (9): 791–806. DOI:10.1101/gr.6.9.791. PMID8889548.
Sasaki Y, Takahashi T, Tanaka I, et al. (1997). „Expression of prostacyclin receptor in human megakaryocytes.”. Blood90 (3): 1039–46. PMID9242534.
Fisch A, Tobusch K, Veit K, et al. (1997). „Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.”. Circulation96 (3): 756–60. PMID9264479.
Smyth EM, Li WH, FitzGerald GA (1998). „Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase c.”. J. Biol. Chem.273 (36): 23258–66. DOI:10.1074/jbc.273.36.23258. PMID9722557.
Kömhoff M, Lesener B, Nakao K, et al. (1999). „Localization of the prostacyclin receptor in human kidney.”. Kidney Int.54 (6): 1899–908. DOI:10.1046/j.1523-1755.1998.00213.x. PMID9853255.
Hayes JS, Lawler OA, Walsh MT, Kinsella BT (1999). „The prostacyclin receptor is isoprenylated. Isoprenylation is required for efficient receptor-effector coupling.”. J. Biol. Chem.274 (34): 23707–18. DOI:10.1074/jbc.274.34.23707. PMID10446129.
Smyth EM, Austin SC, Reilly MP, FitzGerald GA (2000). „Internalization and sequestration of the human prostacyclin receptor.”. J. Biol. Chem.275 (41): 32037–45. DOI:10.1074/jbc.M003873200. PMID10889200.
Lawler OA, Miggin SM, Kinsella BT (2001). „Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling.”. J. Biol. Chem.276 (36): 33596–607. DOI:10.1074/jbc.M104434200. PMID11443126.
Zhang Z, Austin SC, Smyth EM (2001). „Glycosylation of the human prostacyclin receptor: role in ligand binding and signal transduction.”. Mol. Pharmacol.60 (3): 480–7. PMID11502878.
„Prostanoid Receptors: IP1”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2016-03-03.